Google News Alert for: thyroid
| FDA vote split for liraglutide use in patients with type 2 diabetes Endocrine Today - Thorofare,NJ,USA The committee also focused on findings from liraglutide studies demonstrating benign and malignant thyroid C-cell tumors in rats and mice. ... See all stories on this topic |
| Roger Ebert: Two Thumbs Up! Just Jared - New York,NY,USA The 66-year-old film icon has been battling thyroid cancer since 2002 and in 2006 had surgery to combat the cancer. The surgery saved his life, however, ... See all stories on this topic |
| International Formula Council (IFC) Reassures Parents about ... PR Newswire (press release) - New York,NY,USA All infant formulas manufactured in the US contain iodine, as required by the FDA, to aid in the development of the baby's brain and thyroid. ... See all stories on this topic |
| BIOTECH STOCKS Diabetes-drug hurdles weigh on drug stocks MarketWatch - USA "As anticipated, cardiovascular risk and pancreatitis were not a concern during yesterday's panel, but risks of thyroid cancer were completely unanticipated ... See all stories on this topic |
| FDA Faces Tough Choice On New Diabetes Drug Forbes - NY,USA Does a promising new class of diabetes drugs boost the risk of a rare thyroid tumor that may take decades to develop? That's the confusing and almost ... See all stories on this topic |
| Perchlorate found in infant formula -- CDC New York Times - United States The chemical can inhibit the thyroid gland's iodine uptake, interfering with fetal development. The highest levels of perchlorate were found in formulas ... See all stories on this topic |
| Sector Snap: FDA concerns weigh on diabetes drugs Forbes - NY,USA But studies suggested it caused cancerous thyroid tumors in rats and mice, raising concern for the FDA panel. The drug is considered the most likely ... See all stories on this topic |
| US FDA seeks input on Novo drug heart, tumor risk Reuters - USA CO) proposed diabetes drug, liraglutide, as well as thyroid tumors in rodents, documents released on Tuesday said. Few major cardiovascular problems were ... See all stories on this topic |
| Lazard downgrades Amylin to hold on FDA concerns MarketWatch - USA Late Thursday, an FDA panel reviewing liraglutide's application expressed concnern over a study that indicated it might trigger thyroid cancer tumors in ... See all stories on this topic |
| US HOT STOCKS: Research In Motion, Global Payments Wall Street Journal - USA Late Thursday, an expert panel of the US Food and Drug Administration came to a split vote on whether data on a type of thyroid tumors seen in rodent ... See all stories on this topic |
This once a day Google Alert is brought to you by Google.
Create another alert.
Manage your alerts.
No comments:
Post a Comment